Glenmark generic of K-Dur approved
MUMBAI, India — Glenmark Pharmaceuticals Inc. USA has received final Food and Drug Administration approval for potassium chloride extended-release tablets. Glenmark said Wednesday that its potassium chloride ER tablets, which come in dosages of 10 mEq (750 mg) and 20 mEq (1500 mg), are a generic version of K-Dur ER tablets from Merck Sharp and
